nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—liver cancer—hepatitis B	0.441	1	CtDrD
Doxorubicin—NOS2—hepatitis B	0.23	1	CbGaD
Doxorubicin—ABCC3—Lamivudine—hepatitis B	0.0646	0.381	CbGbCtD
Doxorubicin—ABCC1—Lamivudine—hepatitis B	0.0397	0.234	CbGbCtD
Doxorubicin—ABCC2—Lamivudine—hepatitis B	0.0294	0.173	CbGbCtD
Doxorubicin—ABCG2—Lamivudine—hepatitis B	0.0265	0.156	CbGbCtD
Doxorubicin—ABCB1—Lamivudine—hepatitis B	0.00957	0.0564	CbGbCtD
Doxorubicin—ABCB11—bile duct—hepatitis B	0.00574	0.141	CbGeAlD
Doxorubicin—ABCC3—bile duct—hepatitis B	0.00365	0.0897	CbGeAlD
Doxorubicin—ABCC2—bile duct—hepatitis B	0.00292	0.0716	CbGeAlD
Doxorubicin—ABCC6—blood plasma—hepatitis B	0.0014	0.0343	CbGeAlD
Doxorubicin—YWHAG—blood plasma—hepatitis B	0.00132	0.0323	CbGeAlD
Doxorubicin—SLC22A16—blood—hepatitis B	0.00129	0.0316	CbGeAlD
Doxorubicin—RALBP1—blood plasma—hepatitis B	0.00119	0.0292	CbGeAlD
Doxorubicin—NOS3—blood plasma—hepatitis B	0.00117	0.0287	CbGeAlD
Doxorubicin—ABCB8—blood—hepatitis B	0.001	0.0245	CbGeAlD
Doxorubicin—CBR3—blood—hepatitis B	0.000962	0.0236	CbGeAlD
Doxorubicin—ABCC3—blood plasma—hepatitis B	0.000797	0.0196	CbGeAlD
Doxorubicin—ABCB8—liver—hepatitis B	0.000782	0.0192	CbGeAlD
Doxorubicin—AKR1A1—blood—hepatitis B	0.000743	0.0182	CbGeAlD
Doxorubicin—NDUFS7—blood—hepatitis B	0.000675	0.0166	CbGeAlD
Doxorubicin—AURKA—blood—hepatitis B	0.000628	0.0154	CbGeAlD
Doxorubicin—AKR1A1—liver—hepatitis B	0.000581	0.0143	CbGeAlD
Doxorubicin—NOS1—blood—hepatitis B	0.000563	0.0138	CbGeAlD
Doxorubicin—NDUFS2—blood—hepatitis B	0.00056	0.0137	CbGeAlD
Doxorubicin—NDUFS3—blood—hepatitis B	0.000553	0.0136	CbGeAlD
Doxorubicin—NDUFS7—liver—hepatitis B	0.000528	0.013	CbGeAlD
Doxorubicin—DHCR7—blood—hepatitis B	0.000525	0.0129	CbGeAlD
Doxorubicin—ABCC6—blood—hepatitis B	0.000512	0.0126	CbGeAlD
Doxorubicin—AURKA—liver—hepatitis B	0.000491	0.0121	CbGeAlD
Doxorubicin—YWHAG—blood—hepatitis B	0.000482	0.0118	CbGeAlD
Doxorubicin—NDUFS2—liver—hepatitis B	0.000438	0.0107	CbGeAlD
Doxorubicin—RALBP1—blood—hepatitis B	0.000435	0.0107	CbGeAlD
Doxorubicin—NDUFS3—liver—hepatitis B	0.000432	0.0106	CbGeAlD
Doxorubicin—CYP2B6—blood plasma—hepatitis B	0.000429	0.0105	CbGeAlD
Doxorubicin—NOS3—blood—hepatitis B	0.000428	0.0105	CbGeAlD
Doxorubicin—DHCR7—liver—hepatitis B	0.000411	0.0101	CbGeAlD
Doxorubicin—CBR1—blood—hepatitis B	0.000406	0.00997	CbGeAlD
Doxorubicin—AKR1C3—blood—hepatitis B	0.000401	0.00985	CbGeAlD
Doxorubicin—ABCC6—liver—hepatitis B	0.0004	0.00982	CbGeAlD
Doxorubicin—CBR3—Gemcitabine—Lamivudine—hepatitis B	0.00038	0.176	CbGdCrCtD
Doxorubicin—YWHAG—liver—hepatitis B	0.000377	0.00925	CbGeAlD
Doxorubicin—XDH—liver—hepatitis B	0.000368	0.00902	CbGeAlD
Doxorubicin—POR—blood—hepatitis B	0.000366	0.00899	CbGeAlD
Doxorubicin—ABCB11—liver—hepatitis B	0.000359	0.00881	CbGeAlD
Doxorubicin—Pancreatitis—Entecavir—hepatitis B	0.000352	0.00461	CcSEcCtD
Doxorubicin—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.000343	0.0045	CcSEcCtD
Doxorubicin—Amblyopia—Lamivudine—hepatitis B	0.000343	0.00449	CcSEcCtD
Doxorubicin—TOP2A—blood—hepatitis B	0.000342	0.00838	CbGeAlD
Doxorubicin—Pain in extremity—Telbivudine—hepatitis B	0.000341	0.00447	CcSEcCtD
Doxorubicin—RALBP1—liver—hepatitis B	0.00034	0.00835	CbGeAlD
Doxorubicin—AURKA—Floxuridine—Telbivudine—hepatitis B	0.000337	0.157	CbGdCrCtD
Doxorubicin—Hyperaesthesia—Lamivudine—hepatitis B	0.000337	0.00442	CcSEcCtD
Doxorubicin—Migraine—Telbivudine—hepatitis B	0.000336	0.0044	CcSEcCtD
Doxorubicin—Neutropenia—Entecavir—hepatitis B	0.000335	0.00439	CcSEcCtD
Doxorubicin—NOS3—liver—hepatitis B	0.000335	0.00822	CbGeAlD
Doxorubicin—Upper respiratory tract infection—Entecavir—hepatitis B	0.000333	0.00437	CcSEcCtD
Doxorubicin—CYP3A4—blood plasma—hepatitis B	0.000324	0.00795	CbGeAlD
Doxorubicin—Hyperglycaemia—Entecavir—hepatitis B	0.000324	0.00424	CcSEcCtD
Doxorubicin—Dysphonia—Lamivudine—hepatitis B	0.000322	0.00422	CcSEcCtD
Doxorubicin—CYP2D6—blood plasma—hepatitis B	0.000319	0.00782	CbGeAlD
Doxorubicin—CBR1—liver—hepatitis B	0.000318	0.0078	CbGeAlD
Doxorubicin—Blood disorder—Lamivudine—hepatitis B	0.000317	0.00415	CcSEcCtD
Doxorubicin—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.000317	0.00415	CcSEcCtD
Doxorubicin—Renal failure—Entecavir—hepatitis B	0.000314	0.00412	CcSEcCtD
Doxorubicin—AKR1C3—liver—hepatitis B	0.000314	0.0077	CbGeAlD
Doxorubicin—Abdominal pain upper—Telbivudine—hepatitis B	0.000311	0.00408	CcSEcCtD
Doxorubicin—AURKA—Cladribine—Entecavir—hepatitis B	0.000308	0.143	CbGdCrCtD
Doxorubicin—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.000307	0.00402	CcSEcCtD
Doxorubicin—Renal failure—Adefovir Dipivoxil—hepatitis B	0.000307	0.00402	CcSEcCtD
Doxorubicin—Haematuria—Entecavir—hepatitis B	0.000305	0.004	CcSEcCtD
Doxorubicin—Nasopharyngitis—Telbivudine—hepatitis B	0.000305	0.00399	CcSEcCtD
Doxorubicin—Jaundice—Adefovir Dipivoxil—hepatitis B	0.000304	0.00399	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Entecavir—hepatitis B	0.000302	0.00396	CcSEcCtD
Doxorubicin—Gastritis—Telbivudine—hepatitis B	0.000302	0.00395	CcSEcCtD
Doxorubicin—Vasodilation—Lamivudine—hepatitis B	0.000301	0.00395	CcSEcCtD
Doxorubicin—Vasodilation procedure—Lamivudine—hepatitis B	0.000301	0.00395	CcSEcCtD
Doxorubicin—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.000301	0.00394	CcSEcCtD
Doxorubicin—Muscular weakness—Telbivudine—hepatitis B	0.000301	0.00394	CcSEcCtD
Doxorubicin—Haematuria—Adefovir Dipivoxil—hepatitis B	0.000297	0.0039	CcSEcCtD
Doxorubicin—Abdominal distension—Telbivudine—hepatitis B	0.000297	0.00389	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.000295	0.00387	CcSEcCtD
Doxorubicin—Influenza—Telbivudine—hepatitis B	0.000295	0.00386	CcSEcCtD
Doxorubicin—Rectal haemorrhage—Lamivudine—hepatitis B	0.000293	0.00384	CcSEcCtD
Doxorubicin—Bone disorder—Lamivudine—hepatitis B	0.000293	0.00384	CcSEcCtD
Doxorubicin—Viral infection—Lamivudine—hepatitis B	0.000293	0.00384	CcSEcCtD
Doxorubicin—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.000293	0.00384	CcSEcCtD
Doxorubicin—ABCC3—blood—hepatitis B	0.000292	0.00717	CbGeAlD
Doxorubicin—ABCC10—blood—hepatitis B	0.000291	0.00714	CbGeAlD
Doxorubicin—Hepatitis—Entecavir—hepatitis B	0.000287	0.00376	CcSEcCtD
Doxorubicin—POR—liver—hepatitis B	0.000287	0.00703	CbGeAlD
Doxorubicin—Oedema peripheral—Entecavir—hepatitis B	0.000283	0.00371	CcSEcCtD
Doxorubicin—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00028	0.00367	CcSEcCtD
Doxorubicin—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.000278	0.00364	CcSEcCtD
Doxorubicin—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.000277	0.00362	CcSEcCtD
Doxorubicin—Neutropenia—Telbivudine—hepatitis B	0.000275	0.00361	CcSEcCtD
Doxorubicin—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.000275	0.00361	CcSEcCtD
Doxorubicin—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.000275	0.0036	CcSEcCtD
Doxorubicin—Upper respiratory tract infection—Telbivudine—hepatitis B	0.000274	0.00359	CcSEcCtD
Doxorubicin—Inflammation—Lamivudine—hepatitis B	0.000273	0.00358	CcSEcCtD
Doxorubicin—Musculoskeletal pain—Lamivudine—hepatitis B	0.000268	0.00351	CcSEcCtD
Doxorubicin—Eructation—Lamivudine—hepatitis B	0.00026	0.00341	CcSEcCtD
Doxorubicin—Immune system disorder—Entecavir—hepatitis B	0.000259	0.0034	CcSEcCtD
Doxorubicin—Renal failure—Telbivudine—hepatitis B	0.000258	0.00338	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Telbivudine—hepatitis B	0.000257	0.00337	CcSEcCtD
Doxorubicin—AURKA—Cladribine—Telbivudine—hepatitis B	0.000255	0.119	CbGdCrCtD
Doxorubicin—NQO1—liver—hepatitis B	0.000255	0.00625	CbGeAlD
Doxorubicin—Alopecia—Entecavir—hepatitis B	0.000254	0.00332	CcSEcCtD
Doxorubicin—Mental disorder—Entecavir—hepatitis B	0.000251	0.0033	CcSEcCtD
Doxorubicin—Malnutrition—Entecavir—hepatitis B	0.00025	0.00327	CcSEcCtD
Doxorubicin—Neuropathy—Lamivudine—hepatitis B	0.000248	0.00326	CcSEcCtD
Doxorubicin—Aplastic anaemia—Lamivudine—hepatitis B	0.000248	0.00326	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Telbivudine—hepatitis B	0.000248	0.00326	CcSEcCtD
Doxorubicin—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.000244	0.00319	CcSEcCtD
Doxorubicin—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00024	0.00315	CcSEcCtD
Doxorubicin—Mouth ulceration—Lamivudine—hepatitis B	0.000239	0.00314	CcSEcCtD
Doxorubicin—Back pain—Adefovir Dipivoxil—hepatitis B	0.000236	0.00309	CcSEcCtD
Doxorubicin—Hepatitis—Telbivudine—hepatitis B	0.000236	0.00309	CcSEcCtD
Doxorubicin—Hypoaesthesia—Telbivudine—hepatitis B	0.000235	0.00307	CcSEcCtD
Doxorubicin—Pharyngitis—Telbivudine—hepatitis B	0.000234	0.00307	CcSEcCtD
Doxorubicin—ABCC2—blood—hepatitis B	0.000233	0.00573	CbGeAlD
Doxorubicin—Connective tissue disorder—Telbivudine—hepatitis B	0.000232	0.00304	CcSEcCtD
Doxorubicin—Sepsis—Lamivudine—hepatitis B	0.00023	0.00301	CcSEcCtD
Doxorubicin—ABCB1—blood plasma—hepatitis B	0.000229	0.00562	CbGeAlD
Doxorubicin—CYP1B1—blood—hepatitis B	0.000229	0.00561	CbGeAlD
Doxorubicin—ABCC3—liver—hepatitis B	0.000228	0.00561	CbGeAlD
Doxorubicin—ABCC10—liver—hepatitis B	0.000227	0.00558	CbGeAlD
Doxorubicin—Anaemia—Adefovir Dipivoxil—hepatitis B	0.000225	0.00295	CcSEcCtD
Doxorubicin—Lymphadenopathy—Lamivudine—hepatitis B	0.000225	0.00295	CcSEcCtD
Doxorubicin—Leukopenia—Entecavir—hepatitis B	0.000224	0.00293	CcSEcCtD
Doxorubicin—Phlebitis—Lamivudine—hepatitis B	0.000223	0.00292	CcSEcCtD
Doxorubicin—Cough—Adefovir Dipivoxil—hepatitis B	0.000213	0.00279	CcSEcCtD
Doxorubicin—Mediastinal disorder—Telbivudine—hepatitis B	0.000213	0.00278	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.000211	0.00277	CcSEcCtD
Doxorubicin—Myalgia—Adefovir Dipivoxil—hepatitis B	0.000208	0.00272	CcSEcCtD
Doxorubicin—Chest pain—Adefovir Dipivoxil—hepatitis B	0.000208	0.00272	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.000206	0.0027	CcSEcCtD
Doxorubicin—ABCC1—blood—hepatitis B	0.000206	0.00505	CbGeAlD
Doxorubicin—Malnutrition—Telbivudine—hepatitis B	0.000205	0.00269	CcSEcCtD
Doxorubicin—Anaphylactic shock—Entecavir—hepatitis B	0.000204	0.00267	CcSEcCtD
Doxorubicin—Infection—Entecavir—hepatitis B	0.000203	0.00266	CcSEcCtD
Doxorubicin—Renal impairment—Lamivudine—hepatitis B	0.000202	0.00265	CcSEcCtD
Doxorubicin—Dysgeusia—Telbivudine—hepatitis B	0.000201	0.00263	CcSEcCtD
Doxorubicin—AURKA—Gemcitabine—Lamivudine—hepatitis B	0.0002	0.0928	CbGdCrCtD
Doxorubicin—Nervous system disorder—Entecavir—hepatitis B	0.0002	0.00262	CcSEcCtD
Doxorubicin—Back pain—Telbivudine—hepatitis B	0.000199	0.0026	CcSEcCtD
Doxorubicin—Skin disorder—Entecavir—hepatitis B	0.000198	0.0026	CcSEcCtD
Doxorubicin—Muscle spasms—Telbivudine—hepatitis B	0.000197	0.00259	CcSEcCtD
Doxorubicin—Hypoglycaemia—Lamivudine—hepatitis B	0.000197	0.00258	CcSEcCtD
Doxorubicin—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.000195	0.00256	CcSEcCtD
Doxorubicin—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.000195	0.00255	CcSEcCtD
Doxorubicin—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.000193	0.00253	CcSEcCtD
Doxorubicin—Ill-defined disorder—Telbivudine—hepatitis B	0.00019	0.0025	CcSEcCtD
Doxorubicin—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00019	0.00249	CcSEcCtD
Doxorubicin—Migraine—Lamivudine—hepatitis B	0.000189	0.00248	CcSEcCtD
Doxorubicin—Affect lability—Lamivudine—hepatitis B	0.000189	0.00248	CcSEcCtD
Doxorubicin—Malaise—Telbivudine—hepatitis B	0.000185	0.00243	CcSEcCtD
Doxorubicin—Insomnia—Entecavir—hepatitis B	0.000184	0.00242	CcSEcCtD
Doxorubicin—AURKA—Cytarabine—Lamivudine—hepatitis B	0.000184	0.0853	CbGdCrCtD
Doxorubicin—ABCC2—liver—hepatitis B	0.000183	0.00448	CbGeAlD
Doxorubicin—Mood swings—Lamivudine—hepatitis B	0.000182	0.00238	CcSEcCtD
Doxorubicin—Somnolence—Entecavir—hepatitis B	0.000181	0.00238	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.000181	0.00238	CcSEcCtD
Doxorubicin—Dyspepsia—Entecavir—hepatitis B	0.00018	0.00235	CcSEcCtD
Doxorubicin—Cough—Telbivudine—hepatitis B	0.000179	0.00235	CcSEcCtD
Doxorubicin—CYP1B1—liver—hepatitis B	0.000179	0.00439	CbGeAlD
Doxorubicin—Dehydration—Lamivudine—hepatitis B	0.000179	0.00234	CcSEcCtD
Doxorubicin—Liver function test abnormal—Lamivudine—hepatitis B	0.000177	0.00232	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Entecavir—hepatitis B	0.000176	0.00231	CcSEcCtD
Doxorubicin—Fatigue—Entecavir—hepatitis B	0.000176	0.0023	CcSEcCtD
Doxorubicin—Abdominal pain upper—Lamivudine—hepatitis B	0.000175	0.0023	CcSEcCtD
Doxorubicin—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.000175	0.0023	CcSEcCtD
Doxorubicin—Myalgia—Telbivudine—hepatitis B	0.000175	0.00229	CcSEcCtD
Doxorubicin—Chest pain—Telbivudine—hepatitis B	0.000175	0.00229	CcSEcCtD
Doxorubicin—Arthralgia—Telbivudine—hepatitis B	0.000175	0.00229	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.000174	0.00227	CcSEcCtD
Doxorubicin—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.000173	0.00227	CcSEcCtD
Doxorubicin—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.000173	0.00227	CcSEcCtD
Doxorubicin—Discomfort—Telbivudine—hepatitis B	0.000173	0.00226	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.000172	0.00225	CcSEcCtD
Doxorubicin—Nasopharyngitis—Lamivudine—hepatitis B	0.000172	0.00225	CcSEcCtD
Doxorubicin—ABCG2—blood—hepatitis B	0.00017	0.00418	CbGeAlD
Doxorubicin—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.000169	0.00222	CcSEcCtD
Doxorubicin—Muscular weakness—Lamivudine—hepatitis B	0.000169	0.00222	CcSEcCtD
Doxorubicin—Abdominal distension—Lamivudine—hepatitis B	0.000167	0.00219	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Entecavir—hepatitis B	0.000167	0.00219	CcSEcCtD
Doxorubicin—Dysphagia—Lamivudine—hepatitis B	0.000166	0.00218	CcSEcCtD
Doxorubicin—Influenza—Lamivudine—hepatitis B	0.000166	0.00218	CcSEcCtD
Doxorubicin—Nervous system disorder—Telbivudine—hepatitis B	0.000164	0.00215	CcSEcCtD
Doxorubicin—Thrombocytopenia—Telbivudine—hepatitis B	0.000164	0.00215	CcSEcCtD
Doxorubicin—Pancreatitis—Lamivudine—hepatitis B	0.000163	0.00213	CcSEcCtD
Doxorubicin—Skin disorder—Telbivudine—hepatitis B	0.000163	0.00213	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.000163	0.00213	CcSEcCtD
Doxorubicin—Body temperature increased—Entecavir—hepatitis B	0.000161	0.00211	CcSEcCtD
Doxorubicin—Abdominal pain—Entecavir—hepatitis B	0.000161	0.00211	CcSEcCtD
Doxorubicin—ABCC1—liver—hepatitis B	0.000161	0.00395	CbGeAlD
Doxorubicin—Bronchitis—Lamivudine—hepatitis B	0.00016	0.00209	CcSEcCtD
Doxorubicin—Pancytopenia—Lamivudine—hepatitis B	0.000158	0.00207	CcSEcCtD
Doxorubicin—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000157	0.00206	CcSEcCtD
Doxorubicin—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000157	0.00206	CcSEcCtD
Doxorubicin—CYP2B6—blood—hepatitis B	0.000157	0.00385	CbGeAlD
Doxorubicin—Dysuria—Lamivudine—hepatitis B	0.000155	0.00203	CcSEcCtD
Doxorubicin—Neutropenia—Lamivudine—hepatitis B	0.000155	0.00203	CcSEcCtD
Doxorubicin—Pollakiuria—Lamivudine—hepatitis B	0.000153	0.00201	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.000153	0.002	CcSEcCtD
Doxorubicin—Insomnia—Telbivudine—hepatitis B	0.000152	0.00199	CcSEcCtD
Doxorubicin—Paraesthesia—Telbivudine—hepatitis B	0.00015	0.00197	CcSEcCtD
Doxorubicin—Hyperglycaemia—Lamivudine—hepatitis B	0.00015	0.00196	CcSEcCtD
Doxorubicin—Dyspepsia—Telbivudine—hepatitis B	0.000147	0.00193	CcSEcCtD
Doxorubicin—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.000147	0.00192	CcSEcCtD
Doxorubicin—Asthenia—Entecavir—hepatitis B	0.000146	0.00192	CcSEcCtD
Doxorubicin—Renal failure—Lamivudine—hepatitis B	0.000146	0.00191	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Lamivudine—hepatitis B	0.000145	0.0019	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000145	0.0019	CcSEcCtD
Doxorubicin—Fatigue—Telbivudine—hepatitis B	0.000144	0.00189	CcSEcCtD
Doxorubicin—Jaundice—Lamivudine—hepatitis B	0.000144	0.00189	CcSEcCtD
Doxorubicin—Stomatitis—Lamivudine—hepatitis B	0.000144	0.00189	CcSEcCtD
Doxorubicin—Pain—Telbivudine—hepatitis B	0.000143	0.00188	CcSEcCtD
Doxorubicin—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000143	0.00187	CcSEcCtD
Doxorubicin—Sweating—Lamivudine—hepatitis B	0.000142	0.00186	CcSEcCtD
Doxorubicin—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000141	0.00184	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Lamivudine—hepatitis B	0.00014	0.00183	CcSEcCtD
Doxorubicin—Epistaxis—Lamivudine—hepatitis B	0.00014	0.00183	CcSEcCtD
Doxorubicin—Diarrhoea—Entecavir—hepatitis B	0.00014	0.00183	CcSEcCtD
Doxorubicin—Sinusitis—Lamivudine—hepatitis B	0.000139	0.00182	CcSEcCtD
Doxorubicin—Agranulocytosis—Lamivudine—hepatitis B	0.000138	0.00181	CcSEcCtD
Doxorubicin—Feeling abnormal—Telbivudine—hepatitis B	0.000138	0.00181	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Telbivudine—hepatitis B	0.000137	0.0018	CcSEcCtD
Doxorubicin—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000136	0.00178	CcSEcCtD
Doxorubicin—Dizziness—Entecavir—hepatitis B	0.000135	0.00177	CcSEcCtD
Doxorubicin—Rhinitis—Lamivudine—hepatitis B	0.000133	0.00175	CcSEcCtD
Doxorubicin—ABCG2—liver—hepatitis B	0.000133	0.00327	CbGeAlD
Doxorubicin—Hepatitis—Lamivudine—hepatitis B	0.000133	0.00174	CcSEcCtD
Doxorubicin—Abdominal pain—Telbivudine—hepatitis B	0.000132	0.00174	CcSEcCtD
Doxorubicin—Body temperature increased—Telbivudine—hepatitis B	0.000132	0.00174	CcSEcCtD
Doxorubicin—Hypoaesthesia—Lamivudine—hepatitis B	0.000132	0.00173	CcSEcCtD
Doxorubicin—Pharyngitis—Lamivudine—hepatitis B	0.000132	0.00173	CcSEcCtD
Doxorubicin—Connective tissue disorder—Lamivudine—hepatitis B	0.000131	0.00171	CcSEcCtD
Doxorubicin—Vomiting—Entecavir—hepatitis B	0.00013	0.0017	CcSEcCtD
Doxorubicin—TOP2A—Floxuridine—Telbivudine—hepatitis B	0.000129	0.0598	CbGdCrCtD
Doxorubicin—Rash—Entecavir—hepatitis B	0.000129	0.00169	CcSEcCtD
Doxorubicin—Dermatitis—Entecavir—hepatitis B	0.000128	0.00168	CcSEcCtD
Doxorubicin—Headache—Entecavir—hepatitis B	0.000128	0.00167	CcSEcCtD
Doxorubicin—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000127	0.00166	CcSEcCtD
Doxorubicin—Erythema multiforme—Lamivudine—hepatitis B	0.000126	0.00165	CcSEcCtD
Doxorubicin—Rash—Adefovir Dipivoxil—hepatitis B	0.000125	0.00164	CcSEcCtD
Doxorubicin—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000125	0.00164	CcSEcCtD
Doxorubicin—Headache—Adefovir Dipivoxil—hepatitis B	0.000125	0.00163	CcSEcCtD
Doxorubicin—CYP2B6—liver—hepatitis B	0.000123	0.00301	CbGeAlD
Doxorubicin—Nausea—Entecavir—hepatitis B	0.000121	0.00159	CcSEcCtD
Doxorubicin—Asthenia—Telbivudine—hepatitis B	0.00012	0.00158	CcSEcCtD
Doxorubicin—Immune system disorder—Lamivudine—hepatitis B	0.00012	0.00157	CcSEcCtD
Doxorubicin—Mediastinal disorder—Lamivudine—hepatitis B	0.00012	0.00157	CcSEcCtD
Doxorubicin—Chills—Lamivudine—hepatitis B	0.000119	0.00156	CcSEcCtD
Doxorubicin—CYP3A4—blood—hepatitis B	0.000119	0.00291	CbGeAlD
Doxorubicin—Pruritus—Telbivudine—hepatitis B	0.000119	0.00155	CcSEcCtD
Doxorubicin—Nausea—Adefovir Dipivoxil—hepatitis B	0.000118	0.00155	CcSEcCtD
Doxorubicin—TOP2A—Cladribine—Entecavir—hepatitis B	0.000118	0.0546	CbGdCrCtD
Doxorubicin—Alopecia—Lamivudine—hepatitis B	0.000117	0.00154	CcSEcCtD
Doxorubicin—CYP2D6—blood—hepatitis B	0.000117	0.00286	CbGeAlD
Doxorubicin—Erythema—Lamivudine—hepatitis B	0.000116	0.00152	CcSEcCtD
Doxorubicin—Malnutrition—Lamivudine—hepatitis B	0.000116	0.00152	CcSEcCtD
Doxorubicin—Diarrhoea—Telbivudine—hepatitis B	0.000115	0.0015	CcSEcCtD
Doxorubicin—Flatulence—Lamivudine—hepatitis B	0.000114	0.00149	CcSEcCtD
Doxorubicin—Tension—Lamivudine—hepatitis B	0.000114	0.00149	CcSEcCtD
Doxorubicin—Dysgeusia—Lamivudine—hepatitis B	0.000113	0.00148	CcSEcCtD
Doxorubicin—Nervousness—Lamivudine—hepatitis B	0.000112	0.00147	CcSEcCtD
Doxorubicin—Back pain—Lamivudine—hepatitis B	0.000112	0.00147	CcSEcCtD
Doxorubicin—Muscle spasms—Lamivudine—hepatitis B	0.000111	0.00146	CcSEcCtD
Doxorubicin—Dizziness—Telbivudine—hepatitis B	0.000111	0.00145	CcSEcCtD
Doxorubicin—Ill-defined disorder—Lamivudine—hepatitis B	0.000107	0.00141	CcSEcCtD
Doxorubicin—Anaemia—Lamivudine—hepatitis B	0.000107	0.0014	CcSEcCtD
Doxorubicin—Vomiting—Telbivudine—hepatitis B	0.000107	0.0014	CcSEcCtD
Doxorubicin—Rash—Telbivudine—hepatitis B	0.000106	0.00138	CcSEcCtD
Doxorubicin—Dermatitis—Telbivudine—hepatitis B	0.000106	0.00138	CcSEcCtD
Doxorubicin—Headache—Telbivudine—hepatitis B	0.000105	0.00138	CcSEcCtD
Doxorubicin—Malaise—Lamivudine—hepatitis B	0.000104	0.00137	CcSEcCtD
Doxorubicin—Vertigo—Lamivudine—hepatitis B	0.000104	0.00136	CcSEcCtD
Doxorubicin—Syncope—Lamivudine—hepatitis B	0.000104	0.00136	CcSEcCtD
Doxorubicin—Leukopenia—Lamivudine—hepatitis B	0.000104	0.00136	CcSEcCtD
Doxorubicin—Loss of consciousness—Lamivudine—hepatitis B	0.000102	0.00133	CcSEcCtD
Doxorubicin—Cough—Lamivudine—hepatitis B	0.000101	0.00132	CcSEcCtD
Doxorubicin—Convulsion—Lamivudine—hepatitis B	0.0001	0.00131	CcSEcCtD
Doxorubicin—Nausea—Telbivudine—hepatitis B	9.95e-05	0.0013	CcSEcCtD
Doxorubicin—Chest pain—Lamivudine—hepatitis B	9.85e-05	0.00129	CcSEcCtD
Doxorubicin—Myalgia—Lamivudine—hepatitis B	9.85e-05	0.00129	CcSEcCtD
Doxorubicin—Arthralgia—Lamivudine—hepatitis B	9.85e-05	0.00129	CcSEcCtD
Doxorubicin—Anxiety—Lamivudine—hepatitis B	9.82e-05	0.00129	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	9.78e-05	0.00128	CcSEcCtD
Doxorubicin—TOP2A—Cladribine—Telbivudine—hepatitis B	9.76e-05	0.0453	CbGdCrCtD
Doxorubicin—Discomfort—Lamivudine—hepatitis B	9.73e-05	0.00128	CcSEcCtD
Doxorubicin—Dry mouth—Lamivudine—hepatitis B	9.63e-05	0.00126	CcSEcCtD
Doxorubicin—Confusional state—Lamivudine—hepatitis B	9.52e-05	0.00125	CcSEcCtD
Doxorubicin—Oedema—Lamivudine—hepatitis B	9.44e-05	0.00124	CcSEcCtD
Doxorubicin—Anaphylactic shock—Lamivudine—hepatitis B	9.44e-05	0.00124	CcSEcCtD
Doxorubicin—Infection—Lamivudine—hepatitis B	9.38e-05	0.00123	CcSEcCtD
Doxorubicin—Shock—Lamivudine—hepatitis B	9.29e-05	0.00122	CcSEcCtD
Doxorubicin—CYP3A4—liver—hepatitis B	9.27e-05	0.00228	CbGeAlD
Doxorubicin—Nervous system disorder—Lamivudine—hepatitis B	9.26e-05	0.00121	CcSEcCtD
Doxorubicin—Thrombocytopenia—Lamivudine—hepatitis B	9.24e-05	0.00121	CcSEcCtD
Doxorubicin—Skin disorder—Lamivudine—hepatitis B	9.17e-05	0.0012	CcSEcCtD
Doxorubicin—Hyperhidrosis—Lamivudine—hepatitis B	9.13e-05	0.0012	CcSEcCtD
Doxorubicin—CYP2D6—liver—hepatitis B	9.13e-05	0.00224	CbGeAlD
Doxorubicin—Anorexia—Lamivudine—hepatitis B	9e-05	0.00118	CcSEcCtD
Doxorubicin—Hypotension—Lamivudine—hepatitis B	8.82e-05	0.00116	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Lamivudine—hepatitis B	8.6e-05	0.00113	CcSEcCtD
Doxorubicin—Insomnia—Lamivudine—hepatitis B	8.54e-05	0.00112	CcSEcCtD
Doxorubicin—Paraesthesia—Lamivudine—hepatitis B	8.48e-05	0.00111	CcSEcCtD
Doxorubicin—Dyspnoea—Lamivudine—hepatitis B	8.42e-05	0.0011	CcSEcCtD
Doxorubicin—ABCB1—blood—hepatitis B	8.39e-05	0.00206	CbGeAlD
Doxorubicin—Somnolence—Lamivudine—hepatitis B	8.39e-05	0.0011	CcSEcCtD
Doxorubicin—Dyspepsia—Lamivudine—hepatitis B	8.31e-05	0.00109	CcSEcCtD
Doxorubicin—Decreased appetite—Lamivudine—hepatitis B	8.21e-05	0.00108	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Lamivudine—hepatitis B	8.15e-05	0.00107	CcSEcCtD
Doxorubicin—Fatigue—Lamivudine—hepatitis B	8.14e-05	0.00107	CcSEcCtD
Doxorubicin—Pain—Lamivudine—hepatitis B	8.07e-05	0.00106	CcSEcCtD
Doxorubicin—Constipation—Lamivudine—hepatitis B	8.07e-05	0.00106	CcSEcCtD
Doxorubicin—Feeling abnormal—Lamivudine—hepatitis B	7.78e-05	0.00102	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Lamivudine—hepatitis B	7.72e-05	0.00101	CcSEcCtD
Doxorubicin—TOP2A—Gemcitabine—Lamivudine—hepatitis B	7.64e-05	0.0355	CbGdCrCtD
Doxorubicin—Urticaria—Lamivudine—hepatitis B	7.5e-05	0.000983	CcSEcCtD
Doxorubicin—Abdominal pain—Lamivudine—hepatitis B	7.46e-05	0.000978	CcSEcCtD
Doxorubicin—Body temperature increased—Lamivudine—hepatitis B	7.46e-05	0.000978	CcSEcCtD
Doxorubicin—TOP2A—Cytarabine—Lamivudine—hepatitis B	7.02e-05	0.0326	CbGdCrCtD
Doxorubicin—Hypersensitivity—Lamivudine—hepatitis B	6.96e-05	0.000912	CcSEcCtD
Doxorubicin—Asthenia—Lamivudine—hepatitis B	6.77e-05	0.000888	CcSEcCtD
Doxorubicin—Pruritus—Lamivudine—hepatitis B	6.68e-05	0.000875	CcSEcCtD
Doxorubicin—ABCB1—liver—hepatitis B	6.56e-05	0.00161	CbGeAlD
Doxorubicin—Diarrhoea—Lamivudine—hepatitis B	6.46e-05	0.000847	CcSEcCtD
Doxorubicin—Dizziness—Lamivudine—hepatitis B	6.24e-05	0.000818	CcSEcCtD
Doxorubicin—Vomiting—Lamivudine—hepatitis B	6e-05	0.000787	CcSEcCtD
Doxorubicin—Rash—Lamivudine—hepatitis B	5.95e-05	0.00078	CcSEcCtD
Doxorubicin—Dermatitis—Lamivudine—hepatitis B	5.95e-05	0.000779	CcSEcCtD
Doxorubicin—Headache—Lamivudine—hepatitis B	5.91e-05	0.000775	CcSEcCtD
Doxorubicin—Nausea—Lamivudine—hepatitis B	5.61e-05	0.000735	CcSEcCtD
Doxorubicin—NOS2—Circadian rythm related genes—IL6—hepatitis B	1.83e-05	0.000453	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GGT2—hepatitis B	1.79e-05	0.000442	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—GOT2—hepatitis B	1.78e-05	0.00044	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—CDKN2A—hepatitis B	1.78e-05	0.000438	CbGpPWpGaD
Doxorubicin—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—hepatitis B	1.75e-05	0.000433	CbGpPWpGaD
Doxorubicin—CYP2D6—Biological oxidations—GGT1—hepatitis B	1.74e-05	0.000429	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	1.73e-05	0.000428	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—F2—hepatitis B	1.72e-05	0.000424	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—CDKN1A—hepatitis B	1.71e-05	0.000423	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CYP2A6—hepatitis B	1.71e-05	0.000422	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—NOS2—hepatitis B	1.7e-05	0.000419	CbGpPWpGaD
Doxorubicin—NOS2—Disease—GOT1—hepatitis B	1.67e-05	0.000413	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IFNG—hepatitis B	1.67e-05	0.000412	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CCR5—hepatitis B	1.66e-05	0.000409	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CYP2A6—hepatitis B	1.65e-05	0.000407	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—ALB—hepatitis B	1.63e-05	0.000403	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—ALB—hepatitis B	1.63e-05	0.000403	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	1.62e-05	0.0004	CbGpPWpGaD
Doxorubicin—NOS1—Disease—HLA-A—hepatitis B	1.61e-05	0.000399	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—CDKN2A—hepatitis B	1.59e-05	0.000392	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GOT2—hepatitis B	1.55e-05	0.000382	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TGFB1—hepatitis B	1.54e-05	0.000381	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.54e-05	0.00038	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—GOT1—hepatitis B	1.54e-05	0.00038	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—ALB—hepatitis B	1.53e-05	0.000379	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CYP2A6—hepatitis B	1.53e-05	0.000379	CbGpPWpGaD
Doxorubicin—NOS3—Disease—GOT2—hepatitis B	1.51e-05	0.000372	CbGpPWpGaD
Doxorubicin—ABCC2—NRF2 pathway—TGFB1—hepatitis B	1.51e-05	0.000372	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GOT2—hepatitis B	1.49e-05	0.000368	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—IL2—hepatitis B	1.49e-05	0.000368	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	1.49e-05	0.000368	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL2—hepatitis B	1.48e-05	0.000366	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AKR1B1—hepatitis B	1.46e-05	0.000361	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	1.46e-05	0.000359	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCR5—hepatitis B	1.45e-05	0.000358	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—CDKN1A—hepatitis B	1.45e-05	0.000358	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	1.44e-05	0.000356	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—ALB—hepatitis B	1.43e-05	0.000352	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	1.43e-05	0.000352	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AKR1B1—hepatitis B	1.41e-05	0.000349	CbGpPWpGaD
Doxorubicin—NOS1—Disease—NOS2—hepatitis B	1.4e-05	0.000347	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GGT2—hepatitis B	1.4e-05	0.000346	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CYP2A6—hepatitis B	1.39e-05	0.000344	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GOT2—hepatitis B	1.39e-05	0.000342	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—TP53—hepatitis B	1.37e-05	0.000338	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GGT2—hepatitis B	1.36e-05	0.000335	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GOT1—hepatitis B	1.34e-05	0.00033	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GGT1—hepatitis B	1.34e-05	0.00033	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—ALB—hepatitis B	1.3e-05	0.000322	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	1.3e-05	0.000321	CbGpPWpGaD
Doxorubicin—NOS3—Disease—GOT1—hepatitis B	1.3e-05	0.000321	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—CDKN1A—hepatitis B	1.3e-05	0.00032	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GGT1—hepatitis B	1.29e-05	0.000318	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GOT1—hepatitis B	1.29e-05	0.000318	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AKR1B1—hepatitis B	1.29e-05	0.000318	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TP53—hepatitis B	1.27e-05	0.000313	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GOT2—hepatitis B	1.26e-05	0.000311	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	1.26e-05	0.00031	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—IL6—hepatitis B	1.25e-05	0.00031	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CCR5—hepatitis B	1.25e-05	0.000308	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—F2—hepatitis B	1.25e-05	0.000307	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—PTEN—hepatitis B	1.25e-05	0.000307	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—PTEN—hepatitis B	1.25e-05	0.000307	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—hepatitis B	1.24e-05	0.000306	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GGT2—hepatitis B	1.23e-05	0.000305	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HLA-A—hepatitis B	1.22e-05	0.000301	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—ALB—hepatitis B	1.22e-05	0.0003	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GGT1—hepatitis B	1.2e-05	0.000296	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GOT1—hepatitis B	1.2e-05	0.000296	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.17e-05	0.00029	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—PTEN—hepatitis B	1.17e-05	0.000289	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—hepatitis B	1.17e-05	0.000288	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TGFB1—hepatitis B	1.16e-05	0.000287	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—IL2—hepatitis B	1.16e-05	0.000286	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TGFB1—hepatitis B	1.16e-05	0.000286	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CCR5—hepatitis B	1.15e-05	0.000283	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—GGT1—hepatitis B	1.14e-05	0.000281	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CYP2A6—hepatitis B	1.13e-05	0.000279	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HLA-A—hepatitis B	1.12e-05	0.000276	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CDKN2A—hepatitis B	1.11e-05	0.000274	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GGT1—hepatitis B	1.09e-05	0.000269	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GOT1—hepatitis B	1.09e-05	0.000269	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CYP2A6—hepatitis B	1.08e-05	0.000268	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TNF—hepatitis B	1.08e-05	0.000267	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.05e-05	0.00026	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CD4—hepatitis B	1.04e-05	0.000257	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCL10—hepatitis B	1.04e-05	0.000256	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GOT2—hepatitis B	1.02e-05	0.000252	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—hepatitis B	1.01e-05	0.00025	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.01e-05	0.00025	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PTEN—hepatitis B	9.95e-06	0.000246	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GOT2—hepatitis B	9.81e-06	0.000242	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NOS2—hepatitis B	9.74e-06	0.00024	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CCR5—hepatitis B	9.7e-06	0.000239	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ALB—hepatitis B	9.61e-06	0.000237	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—hepatitis B	9.58e-06	0.000236	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HLA-A—hepatitis B	9.46e-06	0.000233	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AKR1B1—hepatitis B	9.44e-06	0.000233	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PTEN—hepatitis B	9.28e-06	0.000229	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CTNNB1—hepatitis B	9.24e-06	0.000228	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—GOT2—hepatitis B	9.18e-06	0.000226	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CDKN1A—hepatitis B	9.07e-06	0.000224	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GGT2—hepatitis B	9.05e-06	0.000223	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TGFB1—hepatitis B	9.03e-06	0.000223	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CDKN1A—hepatitis B	9.03e-06	0.000223	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PTEN—hepatitis B	9.01e-06	0.000222	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—hepatitis B	8.83e-06	0.000218	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GGT1—hepatitis B	8.83e-06	0.000218	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GOT1—hepatitis B	8.83e-06	0.000218	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL10—hepatitis B	8.76e-06	0.000216	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CYP2A6—hepatitis B	8.5e-06	0.00021	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GOT1—hepatitis B	8.47e-06	0.000209	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GGT1—hepatitis B	8.47e-06	0.000209	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL2—hepatitis B	8.39e-06	0.000207	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NOS2—hepatitis B	8.23e-06	0.000203	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CYP2A6—hepatitis B	8.22e-06	0.000203	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CTNNB1—hepatitis B	8.1e-06	0.0002	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	8.05e-06	0.000199	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCR5—hepatitis B	8.04e-06	0.000198	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	7.92e-06	0.000196	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—GOT1—hepatitis B	7.92e-06	0.000195	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CDKN1A—hepatitis B	7.91e-06	0.000195	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PTEN—hepatitis B	7.89e-06	0.000195	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NFKB1—hepatitis B	7.85e-06	0.000194	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CD4—hepatitis B	7.85e-06	0.000194	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	7.71e-06	0.00019	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GOT2—hepatitis B	7.68e-06	0.00019	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	7.66e-06	0.000189	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ALB—hepatitis B	7.62e-06	0.000188	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ALB—hepatitis B	7.53e-06	0.000186	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CYP2A6—hepatitis B	7.48e-06	0.000185	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TGFB1—hepatitis B	7.47e-06	0.000184	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—hepatitis B	7.44e-06	0.000184	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GOT2—hepatitis B	7.43e-06	0.000183	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CD4—hepatitis B	7.21e-06	0.000178	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ALB—hepatitis B	7.1e-06	0.000175	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	7.07e-06	0.000174	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CTNNB1—hepatitis B	6.97e-06	0.000172	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AKR1B1—hepatitis B	6.96e-06	0.000172	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	6.9e-06	0.00017	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—F2—hepatitis B	6.9e-06	0.00017	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	6.89e-06	0.00017	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	6.85e-06	0.000169	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ALB—hepatitis B	6.85e-06	0.000169	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CDKN1A—hepatitis B	6.81e-06	0.000168	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCR5—hepatitis B	6.8e-06	0.000168	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTEN—hepatitis B	6.79e-06	0.000168	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GOT2—hepatitis B	6.76e-06	0.000167	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GGT2—hepatitis B	6.67e-06	0.000165	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GOT1—hepatitis B	6.63e-06	0.000164	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GGT1—hepatitis B	6.63e-06	0.000164	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ALB—hepatitis B	6.63e-06	0.000164	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AKR1B1—hepatitis B	6.56e-06	0.000162	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TGFB1—hepatitis B	6.54e-06	0.000161	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GOT1—hepatitis B	6.42e-06	0.000158	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GGT1—hepatitis B	6.42e-06	0.000158	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CTNNB1—hepatitis B	6.41e-06	0.000158	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ALB—hepatitis B	6.37e-06	0.000157	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GGT2—hepatitis B	6.29e-06	0.000155	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CDKN1A—hepatitis B	6.26e-06	0.000154	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTEN—hepatitis B	6.24e-06	0.000154	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—hepatitis B	6.18e-06	0.000152	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD4—hepatitis B	6.09e-06	0.00015	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	6.05e-06	0.000149	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CCR5—hepatitis B	5.91e-06	0.000146	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	5.85e-06	0.000144	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GGT1—hepatitis B	5.84e-06	0.000144	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GOT1—hepatitis B	5.84e-06	0.000144	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—F2—hepatitis B	5.83e-06	0.000144	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ALB—hepatitis B	5.79e-06	0.000143	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HLA-A—hepatitis B	5.76e-06	0.000142	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	5.71e-06	0.000141	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TGFB1—hepatitis B	5.63e-06	0.000139	CbGpPWpGaD
Doxorubicin—NOS1—Disease—IL6—hepatitis B	5.63e-06	0.000139	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP2A6—hepatitis B	5.48e-06	0.000135	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTEN—hepatitis B	5.42e-06	0.000134	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CTNNB1—hepatitis B	5.41e-06	0.000134	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—hepatitis B	5.38e-06	0.000133	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	5.33e-06	0.000132	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CDKN1A—hepatitis B	5.29e-06	0.00013	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTEN—hepatitis B	5.28e-06	0.00013	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTEN—hepatitis B	5.23e-06	0.000129	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TGFB1—hepatitis B	5.18e-06	0.000128	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS2—hepatitis B	5.01e-06	0.000124	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GOT2—hepatitis B	4.96e-06	0.000122	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL6—hepatitis B	4.93e-06	0.000122	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTEN—hepatitis B	4.86e-06	0.00012	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	4.7e-06	0.000116	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ALB—hepatitis B	4.7e-06	0.000116	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2—hepatitis B	4.65e-06	0.000115	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ALB—hepatitis B	4.5e-06	0.000111	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CTNNB1—hepatitis B	4.49e-06	0.000111	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTEN—hepatitis B	4.42e-06	0.000109	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CDKN1A—hepatitis B	4.38e-06	0.000108	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TGFB1—hepatitis B	4.37e-06	0.000108	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PTEN—hepatitis B	4.37e-06	0.000108	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NFKB1—hepatitis B	4.35e-06	0.000107	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKR1B1—hepatitis B	4.29e-06	0.000106	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GGT1—hepatitis B	4.28e-06	0.000106	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GOT1—hepatitis B	4.28e-06	0.000106	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—hepatitis B	4.24e-06	0.000105	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GGT2—hepatitis B	4.11e-06	0.000101	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP2A6—hepatitis B	4.04e-06	9.98e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2—hepatitis B	3.93e-06	9.69e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—hepatitis B	3.9e-06	9.63e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP2A6—hepatitis B	3.81e-06	9.4e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CTNNB1—hepatitis B	3.79e-06	9.35e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD4—hepatitis B	3.71e-06	9.16e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CDKN1A—hepatitis B	3.7e-06	9.14e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTEN—hepatitis B	3.69e-06	9.12e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NFKB1—hepatitis B	3.68e-06	9.07e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GOT2—hepatitis B	3.66e-06	9.02e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFB1—hepatitis B	3.62e-06	8.95e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	3.58e-06	8.85e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTEN—hepatitis B	3.58e-06	8.84e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—hepatitis B	3.53e-06	8.71e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GOT2—hepatitis B	3.45e-06	8.5e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTEN—hepatitis B	3.44e-06	8.48e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—hepatitis B	3.41e-06	8.42e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CTNNB1—hepatitis B	3.3e-06	8.14e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—hepatitis B	3.3e-06	8.13e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDKN1A—hepatitis B	3.22e-06	7.95e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTEN—hepatitis B	3.21e-06	7.93e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GOT1—hepatitis B	3.16e-06	7.79e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GGT1—hepatitis B	3.16e-06	7.79e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—hepatitis B	3.1e-06	7.66e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFB1—hepatitis B	3.06e-06	7.56e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—hepatitis B	2.98e-06	7.36e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GOT1—hepatitis B	2.97e-06	7.34e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GGT1—hepatitis B	2.97e-06	7.34e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—hepatitis B	2.73e-06	6.74e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTEN—hepatitis B	2.69e-06	6.64e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFB1—hepatitis B	2.66e-06	6.58e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTEN—hepatitis B	2.6e-06	6.43e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—hepatitis B	2.52e-06	6.22e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP2A6—hepatitis B	2.49e-06	6.15e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTEN—hepatitis B	2.37e-06	5.85e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—hepatitis B	2.31e-06	5.7e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—hepatitis B	2.28e-06	5.62e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GOT2—hepatitis B	2.25e-06	5.56e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—hepatitis B	2.01e-06	4.96e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GOT1—hepatitis B	1.94e-06	4.8e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GGT1—hepatitis B	1.94e-06	4.8e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTEN—hepatitis B	1.74e-06	4.29e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—hepatitis B	1.68e-06	4.14e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—hepatitis B	1.58e-06	3.9e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTEN—hepatitis B	1.28e-06	3.16e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTEN—hepatitis B	1.21e-06	2.98e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—hepatitis B	1.03e-06	2.55e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTEN—hepatitis B	7.89e-07	1.95e-05	CbGpPWpGaD
